Pietro Sormanni

Lensfield Road
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 79 publications

Quantifying molecular specificity in excipient-driven antibody solubilization.

Quantifying molecular specificity in excipient-driven antibody solubilization.

Journal: mAbs

Published: August 30, 2026

Prediction of antibody non-specificity using protein language models and biophysical parameters.

Prediction of antibody non-specificity using protein language models and biophysical parameters.

Journal: mAbs

Published: May 27, 2026

Disulphide and sequence-encoded conformational priors guide nanobody structure prediction.

Disulphide and sequence-encoded conformational priors guide nanobody structure prediction.

Journal: bioRxiv : the preprint server for biology

Published: April 29, 2026

Deep learning assessment of nativeness and pairing likelihood for antibody and nanobody design with AbNatiV2.

Deep learning assessment of nativeness and pairing likelihood for antibody and nanobody design with AbNatiV2.

Journal: mAbs

Published: April 07, 2026

A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability.

A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability.

Journal: Nature biotechnology

Published: February 28, 2026

Developability engineering of scFvs enables robust CAR function under transient mRNA expression.

Developability engineering of scFvs enables robust CAR function under transient mRNA expression.

Journal: Scientific reports

Published: February 04, 2026

SurfDiff: protein surface profiling for selective or broadly reactive epitope prioritisation in binder and immunogen design.

SurfDiff: protein surface profiling for selective or broadly reactive epitope prioritisation in binder and immunogen design.

Journal: bioRxiv : the preprint server for biology

Published: January 09, 2026

The NewroBus platform: engineered humanized anti-TfR1 nanobodies for efficient brain delivery.

The NewroBus platform: engineered humanized anti-TfR1 nanobodies for efficient brain delivery.

Journal: Cell communication and signaling : CCS

Published: October 27, 2025

Correction: Modifying recombinant purple acid phosphatase using computational design.

Correction: Modifying recombinant purple acid phosphatase using computational design.

Journal: European biophysics journal : EBJ

Published: August 09, 2025

Bright sorting yields drug-like anti-amyloid antibodies.

Bright sorting yields drug-like anti-amyloid antibodies.

Journal: Trends in pharmacological sciences

Published: May 21, 2025

Development of potent humanized TNFα inhibitory nanobodies for therapeutic applications in TNFα-mediated diseases.

Development of potent humanized TNFα inhibitory nanobodies for therapeutic applications in TNFα-mediated diseases.

Journal: mAbs

Published: May 14, 2025

Targeted Protein Modification with an Antibody-Based System.

Targeted Protein Modification with an Antibody-Based System.

Journal: ACS central science

Published: April 22, 2025

Showing 1-12 of 79

Last Updated: 09/26/2026